You must log in or register to comment.
The drugs selected to undergo negotiations are:
- Eliquis, a blood thinner
- Xarelto, a blood thinner
- Januvia, a diabetes drug
- Jardiance, a diabetes drug
- Enbrel, a rheumatoid arthritis drug
- Imbruvica, a drug for blood cancers
- Farxiga, a drug for diabetes, heart failure and chronic kidney disease
- Entresto, a heart failure drug
- Stelara, a drug for psoriasis and Crohn’s disease
- Fiasp and NovoLog, for diabetes
(via NBC)
There are a lot of comments in here pointing out how those are older people medication. I’m 33 and I’ll be on eliquis for the rest of my life. Without good insurance it’s over 600 bucks a month. This is phenomenal news for my future, and for my safety. While the vast majority is medications will impact the over 65 category, there are a lot of us who are still taking these too.
And until you are 70ish+ to take Medicare they will be milking every last dime from you they can,